• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗期间后扩张用于优化支架的当代应用;来自荷兰心脏注册研究的结果

Contemporary Use of Post-Dilatation for Stent Optimization During Percutaneous Coronary Intervention; Results From the Netherlands Heart Registration.

作者信息

van Beek K A J, Timmermans M J C, Derks L, Cheng J M, Kraaijeveld A O, Arkenbout E K, Schotborgh C E, Brouwer J, Claessen B E, Lipsic E, Polad J, van Nunen L X, Sjauw K, van Veghel D, Tonino P A, Teeuwen K

机构信息

Heart Centre, Catharina Hospital, Eindhoven, The Netherlands.

PCI Registration, Netherlands Heart Registration, Utrecht, The Netherlands.

出版信息

Catheter Cardiovasc Interv. 2025 Mar;105(4):870-877. doi: 10.1002/ccd.31404. Epub 2025 Jan 8.

DOI:10.1002/ccd.31404
PMID:39777867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11874260/
Abstract

BACKGROUNDS

Post-dilatation after stenting with a non-compliant (NC) balloon can be used to improve overall percutaneous coronary intervention (PCI) result. Due to lack of evidence on the effect of post-dilatation on adverse clinical endpoints there is no consensus whether post-dilatation should be used routinely. The aim of the current study was to determine the contemporary practice of post-dilatation.

METHODS

This study included patients from the Netherlands Heart Registration who underwent PCI between the 4th quarter of 2020 and the 3rd quarter of 2021. The primary endpoint was the rate of post-dilatation with a NC balloon. Secondary endpoints included differences in baseline and procedural characteristics of patients that received post-dilatation and patients that did not receive post-dilatation.

RESULTS

Out of 12,960 patients from 11 hospitals, 49.9% underwent post-dilatation. There was a variety in post-dilatation between hospitals ranging from 29.3% to 82.7% and among operators ranging from 15.9% to 90.5%. Post-dilatation was used less frequent in patients presenting with ST-elevation myocardial infarction or out of hospital cardiac arrest. Multivessel and left main PCI, long stent length and use of intracoronary imaging and calcium modification were associated with increased use of post-dilatation. When imaging was used, the percentage of post-dilatation was 79.4%.

CONCLUSIONS

In the Netherlands, stent optimization with post-dilatation using NC balloon is performed in only half of the patients undergoing PCI, with variations in frequency across centres and operators. Post-dilatation is more often used in cases of complex PCI and when intracoronary imaging or calcium modification techniques are used.

摘要

背景

使用非顺应性(NC)球囊进行支架置入术后的后扩张可用于改善整体经皮冠状动脉介入治疗(PCI)效果。由于缺乏关于后扩张对不良临床终点影响的证据,对于是否应常规使用后扩张尚无共识。本研究的目的是确定后扩张的当代实践情况。

方法

本研究纳入了来自荷兰心脏注册中心在2020年第四季度至2021年第三季度期间接受PCI的患者。主要终点是使用NC球囊进行后扩张的比例。次要终点包括接受后扩张和未接受后扩张患者的基线和手术特征差异。

结果

在来自11家医院的12960例患者中,49.9%接受了后扩张。各医院之间后扩张的比例有所不同,范围从29.3%至82.7%,各操作者之间的比例范围从15.9%至90.5%。ST段抬高型心肌梗死或院外心脏骤停患者使用后扩张的频率较低。多支血管和左主干PCI、较长的支架长度以及冠状动脉内成像和钙化修饰的使用与后扩张的使用增加相关。当使用成像时,后扩张的比例为79.4%。

结论

在荷兰,仅一半接受PCI的患者使用NC球囊进行后扩张以优化支架,各中心和操作者之间的频率存在差异。后扩张在复杂PCI病例以及使用冠状动脉内成像或钙化修饰技术时更常使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae88/11874260/9764ef712550/CCD-105-870-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae88/11874260/ee811650e812/CCD-105-870-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae88/11874260/87ce6bfbda01/CCD-105-870-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae88/11874260/9764ef712550/CCD-105-870-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae88/11874260/ee811650e812/CCD-105-870-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae88/11874260/87ce6bfbda01/CCD-105-870-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae88/11874260/9764ef712550/CCD-105-870-g001.jpg

相似文献

1
Contemporary Use of Post-Dilatation for Stent Optimization During Percutaneous Coronary Intervention; Results From the Netherlands Heart Registration.经皮冠状动脉介入治疗期间后扩张用于优化支架的当代应用;来自荷兰心脏注册研究的结果
Catheter Cardiovasc Interv. 2025 Mar;105(4):870-877. doi: 10.1002/ccd.31404. Epub 2025 Jan 8.
2
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).伴有非ST段抬高型心肌梗死的糖尿病合并多支冠状动脉疾病患者的血运重建趋势:来自国家心血管数据注册库急性冠状动脉治疗和干预结果网络注册库-遵循指南行动(NCDR ACTION注册库-GWTG)的见解
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.
3
Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.支架代际对行罪犯血管血运重建或多支血管血运重建的多支血管病变 ST 段抬高型心肌梗死患者 2 年临床结局的影响。
Catheter Cardiovasc Interv. 2020 Feb;95(2):E40-E55. doi: 10.1002/ccd.28440. Epub 2019 Aug 18.
4
A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions.药物洗脱支架植入术与药物涂层球囊血管成形术治疗左主干分叉支架内再狭窄病变的对比研究。
BMC Cardiovasc Disord. 2020 Feb 18;20(1):83. doi: 10.1186/s12872-020-01381-9.
5
Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty: A Long-Term in-Stent Restenosis Study.药物涂层球囊与药物洗脱支架或普通球囊血管成形术:一项关于支架内再狭窄的长期研究
J Am Heart Assoc. 2024 Dec 3;13(23):e036839. doi: 10.1161/JAHA.124.036839. Epub 2024 Nov 22.
6
Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.性别对既往未经治疗的冠状动脉疾病患者使用裸金属支架和药物洗脱支架进行经皮冠状动脉介入治疗后3年预后的影响:来自RESEARCH(鹿特丹心脏病医院雷帕霉素洗脱支架评估)和T-SEARCH(鹿特丹心脏病医院紫杉醇支架评估)注册研究的见解
JACC Cardiovasc Interv. 2009 Jul;2(7):603-10. doi: 10.1016/j.jcin.2009.03.016.
7
Temporal trends in percutaneous coronary interventions thru the drug eluting stent era: Insights from 18,641 procedures performed over 12-year period.药物洗脱支架时代经皮冠状动脉介入治疗的时间趋势:12 年期间完成的 18641 例手术的见解。
Catheter Cardiovasc Interv. 2018 Oct 1;92(4):E262-E270. doi: 10.1002/ccd.27375. Epub 2017 Oct 13.
8
The independent value of a direct stenting strategy on early and late clinical outcomes in patients undergoing elective percutaneous coronary intervention.直接支架置入策略对择期经皮冠状动脉介入治疗患者早期和晚期临床结局的独立价值。
Catheter Cardiovasc Interv. 2013 May;81(6):949-56. doi: 10.1002/ccd.24581. Epub 2013 Feb 12.
9
2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.超越SYNTAX(TAXUS药物洗脱支架经皮冠状动脉介入治疗与心脏手术协同作用)研究的奥地利多支血管TAXUS支架(AUTAX)注册研究的2年结果。
JACC Cardiovasc Interv. 2009 Aug;2(8):718-27. doi: 10.1016/j.jcin.2009.05.019.
10
Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures.血管内超声指导下经皮冠状动脉介入治疗对复杂手术患者长期临床结局的影响。
JACC Cardiovasc Interv. 2019 Apr 8;12(7):607-620. doi: 10.1016/j.jcin.2019.01.227. Epub 2019 Mar 13.

本文引用的文献

1
2024 ESC Guidelines for the management of chronic coronary syndromes.2024年欧洲心脏病学会慢性冠状动脉综合征管理指南
Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.
2
Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.血管内成像引导下冠状动脉药物洗脱支架植入术:一项更新的网状荟萃分析。
Lancet. 2024 Mar 2;403(10429):824-837. doi: 10.1016/S0140-6736(23)02454-6. Epub 2024 Feb 21.
3
Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL-LM.
近端优化技术与经皮冠状动脉介入治疗左主干病变:POTENTIAL-LM研究
Catheter Cardiovasc Interv. 2024 Feb;103(3):417-424. doi: 10.1002/ccd.30961. Epub 2024 Jan 31.
4
Results of systematic patient outcome monitoring: Does post-dilatation during angiography-guided percutaneous coronary intervention improve clinical outcomes?
Hellenic J Cardiol. 2025 Mar-Apr;82:26-33. doi: 10.1016/j.hjc.2023.11.004. Epub 2023 Nov 16.
5
Mitigating the risk of flow deterioration by deferring stent optimization in STEMI patients with large thrombus burden: Insights from a prospective cohort study.通过延迟 ST 段抬高型心肌梗死(STEMI)患者大血栓负荷的支架优化来降低血流恶化风险:一项前瞻性队列研究的结果。
BMC Cardiovasc Disord. 2023 Oct 12;23(1):506. doi: 10.1186/s12872-023-03540-0.
6
The Index of Microcirculatory Resistance After Primary PCI: A Pooled Analysis of Individual Patient Data.直接经皮冠状动脉介入治疗后微血管阻力指数:一项个体患者数据分析的汇总分析。
JACC Cardiovasc Interv. 2023 Oct 9;16(19):2383-2392. doi: 10.1016/j.jcin.2023.08.030.
7
Intravascular Imaging-Guided or Angiography-Guided Complex PCI.血管内影像学指导或血管造影指导下的复杂 PCI。
N Engl J Med. 2023 May 4;388(18):1668-1679. doi: 10.1056/NEJMoa2216607. Epub 2023 Mar 5.
8
Data quality and auditing within the Netherlands Heart Registration: using the PCI registry as an example.荷兰心脏注册中的数据质量与审核:以PCI注册为例
Neth Heart J. 2023 Sep;31(9):334-339. doi: 10.1007/s12471-022-01752-1. Epub 2023 Jan 16.
9
Rates of Intracoronary Imaging Optimization in Contemporary Percutaneous Coronary Intervention: A Report From the BMC2 Registry.当代经皮冠状动脉介入治疗中冠状动脉影像学优化的比率:来自 BMC2 注册研究的报告。
Circ Cardiovasc Interv. 2022 Oct;15(10):e012182. doi: 10.1161/CIRCINTERVENTIONS.122.012182. Epub 2022 Oct 18.
10
Coronary In-Stent Restenosis: JACC State-of-the-Art Review.冠状动脉支架内再狭窄:JACC 最新综述
J Am Coll Cardiol. 2022 Jul 26;80(4):348-372. doi: 10.1016/j.jacc.2022.05.017.